ID

32604

Descrição

A Safety and Efficacy Study of Carboplatin, Paclitaxel, Bevacizumab and CA4P in Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00653939

Link

https://clinicaltrials.gov/show/NCT00653939

Palavras-chave

Versões (1)
  1. 08/11/2018 08/11/2018 -
Titular dos direitos

See clinicaltrials.gov

Transferido a

8 de novembro de 2018

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Tumors NCT00653939

Inglês

Eligibility Tumors NCT00653939

1 Formulários  
  1. StudyEvent: Eligibility
    1. Eligibility Tumors NCT00653939
Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
pathologically confirmed stage iiib nsclc with malignant pleural effusion, or stage iv disease
Descrição

Non-Small Cell Lung Carcinoma TNM clinical staging | Pleural Effusion, Malignant | Disease TNM clinical staging

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C3258246
UMLS CUI [2]
C0080032
UMLS CUI [3,1]
C0012634
UMLS CUI [3,2]
C3258246
measurable disease on ct scan (by the response evaluation criteria in solid tumors [recist] criteria)
Descrição

Measurable Disease CT scan

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C0040405
eastern cooperative oncology group (ecog) performance status (ps) of 0 or 1 (which means able to independently care for self and to perform light work) .
Descrição

ECOG performance status

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1520224
adequate blood counts
Descrição

Blood Count

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0005771
adequate liver and kidney function
Descrição

Liver function | Renal function

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0232741
UMLS CUI [2]
C0232804
subjects or their legal representatives must be able to read, understand and provide written informed consent to participate in the trial.
Descrição

Informed Consent | Informed Consent Patient Representatives

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0021430
UMLS CUI [2,1]
C0021430
UMLS CUI [2,2]
C0030701
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
predominant squamous cell nsclc histology.
Descrição

Squamous non-small cell lung cancer predominant

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C4509816
UMLS CUI [1,2]
C1542147
history of treatment for nsclc with chemotherapy, biological therapy, immunotherapy (surgery or radiation therapy are accepted)
Descrição

Chemotherapy NSCLC | Biological treatment NSCLC | Immunotherapy NSCLC | Operative Surgical Procedures Acceptable | Therapeutic radiology procedure Acceptable

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0007131
UMLS CUI [2,1]
C1531518
UMLS CUI [2,2]
C0007131
UMLS CUI [3,1]
C0021083
UMLS CUI [3,2]
C0007131
UMLS CUI [4,1]
C0543467
UMLS CUI [4,2]
C1879533
UMLS CUI [5,1]
C1522449
UMLS CUI [5,2]
C1879533
brain (cns) metastasis by head ct scan or mri
Descrição

Metastatic malignant neoplasm to brain CT scan of head | Metastatic malignant neoplasm to brain MRI of head

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0220650
UMLS CUI [1,2]
C0202691
UMLS CUI [2,1]
C0220650
UMLS CUI [2,2]
C0412674
subjects with history of prior malignancy except for curatively treated basal cell carcinoma of the skin; cervical intra-epithelial neoplasia; or localized prostate cancer with a current prostate specific antigen (psa) of < 4.0 mg/dl. subjects with other curatively treated malignancies who have no evidence of metastatic disease and >2 year disease free interval may be entered after discussion with the medical monitor.
Descrição

Malignant Neoplasms | Exception Curative treatment Basal cell carcinoma | Exception Cervical Intraepithelial Neoplasia | Exception Prostate carcinoma Localized PSA measurement | Exception Curative treatment Cancer Other | Exception Neoplasm Metastasis Absent | Exception Disease Free of

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C1273390
UMLS CUI [2,3]
C0007117
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0206708
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0600139
UMLS CUI [4,3]
C0392752
UMLS CUI [4,4]
C0201544
UMLS CUI [5,1]
C1705847
UMLS CUI [5,2]
C1273390
UMLS CUI [5,3]
C1707251
UMLS CUI [6,1]
C1705847
UMLS CUI [6,2]
C0027627
UMLS CUI [6,3]
C0332197
UMLS CUI [7,1]
C1705847
UMLS CUI [7,2]
C0012634
UMLS CUI [7,3]
C0332296
history of bleeding disorders, particularly coughing up ≥ ½ teaspoon bright red blood during the last 3 months
Descrição

Blood Coagulation Disorders

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0005779
certain cardiac disorders such as recent myocardial infarction (mi), severe congestive heart failure, certain types of abnormal cardiac rhythm
Descrição

Heart Diseases | Myocardial Infarction | Congestive heart failure Severe | Cardiac Arrhythmia

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0018799
UMLS CUI [2]
C0027051
UMLS CUI [3,1]
C0018802
UMLS CUI [3,2]
C0205082
UMLS CUI [4]
C0003811
uncontrolled high blood pressure despite medications
Descrição

Uncontrolled hypertension | Pharmaceutical Preparations Resistant

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1868885
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C0332325
uncontrolled, clinically significant active infection.
Descrição

Communicable Disease Uncontrolled

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0205318
known hiv
Descrição

HIV Infection

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0019693
known hypersensitivity to any of the components of ca4p, paclitaxel, carboplatin, bevacizumab, or radiologic contrast dyes.
Descrição

Hypersensitivity CA4P | Paclitaxel allergy | Carboplatin allergy | Hypersensitivity Bevacizumab | Contrast dye allergy

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0962508
UMLS CUI [2]
C0570707
UMLS CUI [3]
C0570701
UMLS CUI [4,1]
C0020517
UMLS CUI [4,2]
C0796392
UMLS CUI [5]
C0742797
details of the above and additional inclusion and exclusion criteria can be discussed with an investigator.
Descrição

Eligibility Criteria Additional

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C1524062
Voltar ao início da página

Similar models

Eligibility Tumors NCT00653939

1 Formulários
  1. StudyEvent: Eligibility
    1. Eligibility Tumors NCT00653939
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
Non-Small Cell Lung Carcinoma TNM clinical staging | Pleural Effusion, Malignant | Disease TNM clinical staging
Item
pathologically confirmed stage iiib nsclc with malignant pleural effusion, or stage iv disease
boolean
C0007131 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
C0080032 (UMLS CUI [2])
C0012634 (UMLS CUI [3,1])
C3258246 (UMLS CUI [3,2])
Measurable Disease CT scan
Item
measurable disease on ct scan (by the response evaluation criteria in solid tumors [recist] criteria)
boolean
C1513041 (UMLS CUI [1,1])
C0040405 (UMLS CUI [1,2])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status (ps) of 0 or 1 (which means able to independently care for self and to perform light work) .
boolean
C1520224 (UMLS CUI [1])
Blood Count
Item
adequate blood counts
boolean
C0005771 (UMLS CUI [1])
Liver function | Renal function
Item
adequate liver and kidney function
boolean
C0232741 (UMLS CUI [1])
C0232804 (UMLS CUI [2])
Informed Consent | Informed Consent Patient Representatives
Item
subjects or their legal representatives must be able to read, understand and provide written informed consent to participate in the trial.
boolean
C0021430 (UMLS CUI [1])
C0021430 (UMLS CUI [2,1])
C0030701 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Squamous non-small cell lung cancer predominant
Item
predominant squamous cell nsclc histology.
boolean
C4509816 (UMLS CUI [1,1])
C1542147 (UMLS CUI [1,2])
Chemotherapy NSCLC | Biological treatment NSCLC | Immunotherapy NSCLC | Operative Surgical Procedures Acceptable | Therapeutic radiology procedure Acceptable
Item
history of treatment for nsclc with chemotherapy, biological therapy, immunotherapy (surgery or radiation therapy are accepted)
boolean
C0392920 (UMLS CUI [1,1])
C0007131 (UMLS CUI [1,2])
C1531518 (UMLS CUI [2,1])
C0007131 (UMLS CUI [2,2])
C0021083 (UMLS CUI [3,1])
C0007131 (UMLS CUI [3,2])
C0543467 (UMLS CUI [4,1])
C1879533 (UMLS CUI [4,2])
C1522449 (UMLS CUI [5,1])
C1879533 (UMLS CUI [5,2])
Metastatic malignant neoplasm to brain CT scan of head | Metastatic malignant neoplasm to brain MRI of head
Item
brain (cns) metastasis by head ct scan or mri
boolean
C0220650 (UMLS CUI [1,1])
C0202691 (UMLS CUI [1,2])
C0220650 (UMLS CUI [2,1])
C0412674 (UMLS CUI [2,2])
Malignant Neoplasms | Exception Curative treatment Basal cell carcinoma | Exception Cervical Intraepithelial Neoplasia | Exception Prostate carcinoma Localized PSA measurement | Exception Curative treatment Cancer Other | Exception Neoplasm Metastasis Absent | Exception Disease Free of
Item
subjects with history of prior malignancy except for curatively treated basal cell carcinoma of the skin; cervical intra-epithelial neoplasia; or localized prostate cancer with a current prostate specific antigen (psa) of < 4.0 mg/dl. subjects with other curatively treated malignancies who have no evidence of metastatic disease and >2 year disease free interval may be entered after discussion with the medical monitor.
boolean
C0006826 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C1273390 (UMLS CUI [2,2])
C0007117 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0206708 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C0600139 (UMLS CUI [4,2])
C0392752 (UMLS CUI [4,3])
C0201544 (UMLS CUI [4,4])
C1705847 (UMLS CUI [5,1])
C1273390 (UMLS CUI [5,2])
C1707251 (UMLS CUI [5,3])
C1705847 (UMLS CUI [6,1])
C0027627 (UMLS CUI [6,2])
C0332197 (UMLS CUI [6,3])
C1705847 (UMLS CUI [7,1])
C0012634 (UMLS CUI [7,2])
C0332296 (UMLS CUI [7,3])
Blood Coagulation Disorders
Item
history of bleeding disorders, particularly coughing up ≥ ½ teaspoon bright red blood during the last 3 months
boolean
C0005779 (UMLS CUI [1])
Heart Diseases | Myocardial Infarction | Congestive heart failure Severe | Cardiac Arrhythmia
Item
certain cardiac disorders such as recent myocardial infarction (mi), severe congestive heart failure, certain types of abnormal cardiac rhythm
boolean
C0018799 (UMLS CUI [1])
C0027051 (UMLS CUI [2])
C0018802 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
C0003811 (UMLS CUI [4])
Uncontrolled hypertension | Pharmaceutical Preparations Resistant
Item
uncontrolled high blood pressure despite medications
boolean
C1868885 (UMLS CUI [1])
C0013227 (UMLS CUI [2,1])
C0332325 (UMLS CUI [2,2])
Communicable Disease Uncontrolled
Item
uncontrolled, clinically significant active infection.
boolean
C0009450 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
HIV Infection
Item
known hiv
boolean
C0019693 (UMLS CUI [1])
Hypersensitivity CA4P | Paclitaxel allergy | Carboplatin allergy | Hypersensitivity Bevacizumab | Contrast dye allergy
Item
known hypersensitivity to any of the components of ca4p, paclitaxel, carboplatin, bevacizumab, or radiologic contrast dyes.
boolean
C0020517 (UMLS CUI [1,1])
C0962508 (UMLS CUI [1,2])
C0570707 (UMLS CUI [2])
C0570701 (UMLS CUI [3])
C0020517 (UMLS CUI [4,1])
C0796392 (UMLS CUI [4,2])
C0742797 (UMLS CUI [5])
Eligibility Criteria Additional
Item
details of the above and additional inclusion and exclusion criteria can be discussed with an investigator.
boolean
C1516637 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial